Union City, CA, United States of America

Xiaojun Li

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Hongene Biotech Corporation. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaojun Li. Retrieved from https://idiyas.com/inventor/xiaojun-li-j3keccih

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Xiaojun Li

Introduction

Xiaojun Li is an accomplished inventor based in Union City, California. He has made significant contributions to the field of biotechnology, particularly in the development of novel compounds and methods for drug delivery. With a total of two patents to his name, his work is paving the way for advancements in therapeutic applications.

Latest Patents

Xiaojun Li's latest patents include "Lipid-pegylated compounds, preparations and uses thereof" and "Functionalized N-acetylgalactosamine analogs." The first patent focuses on lipid-PEGylated solid support and phosphoramidite derivatives, detailing methods for their preparation and applications in delivering oligonucleotide drugs to cellular targets. The second patent discusses functionalized N-acetylgalactosamine analogs, emphasizing methods of making these compounds and their potential uses in targeted delivery of oligonucleotide-based therapeutics.

Career Highlights

Xiaojun Li is currently associated with Hongene Biotech Corporation, where he continues to innovate and contribute to the field of biotechnology. His expertise in drug delivery systems and compound development has positioned him as a key player in his organization.

Collaborations

Some of Xiaojun Li's notable coworkers include Wing C Poon and David Yu. Their collaborative efforts enhance the research and development initiatives at Hongene Biotech Corporation.

Conclusion

Xiaojun Li's innovative work in biotechnology, particularly in drug delivery systems, showcases his commitment to advancing therapeutic solutions. His patents reflect a deep understanding of complex biochemical processes and a dedication to improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…